The majority of newly diagnosed myeloma patients do not fulfill the inclusion criteria in clinical phase III trials
暂无分享,去创建一个
A. Vangsted | N. Abildgaard | N. F. Andersen | P. Gimsing | T. Klausen | H. Gregersen | U. Frølund | C. Helleberg
暂无分享,去创建一个
A. Vangsted | N. Abildgaard | N. F. Andersen | P. Gimsing | T. Klausen | H. Gregersen | U. Frølund | C. Helleberg